First Successful Clinical Trial of VU319 Brings Alzheimer'sTreatment One Step Closer Dec ... such as figuring out a taxi route or the best way to navigate to a hospital -- could lead to lower ...
This step is important to make sure that only the best and safest treatments are tested on humans in clinical trials. The team examined postmortem brain tissues from Alzheimer's patients using ...
Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.
While nearly 7 million Americans aged 65 and older suffer from Alzheimer's disease, experts are reflecting on the advances in diagnosis, treatment and risk management that have been made in 2024.
The headset, developed by researchers at Cornell University in New York, could help reveal how the brain navigates and controls memory function, giving researchers new insights into disorders such as ...
Blarcamesine is an orally once daily administered small molecule for the potential treatment of patients with Alzheimer’s disease. “The EMA filing acceptance for blarcamesine to review the ...
Results that may be inaccessible to you are currently showing.